Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Alberti

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
BMC Cancer|March 21, 2006
CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathwaysNathalie Voorzanger-Rousselot, Laurent Alberti, Jean-Yves Blay
Bulletin Du Cancer|March 8, 2005
Targeted cancer therapiesJean-Yves Blay, Axel Le Cesne, Laurent Alberti, et al.
Cancer Research|January 25, 2005
A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitorLaurent Alberti, Thoma Bachelot, Adeline Duc, et al.
Plos One|December 4, 2009
Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibodyAngélique Gougelet, Adeline Mansuy, Jean-Yves Blay, et al.
Ultrasonics|October 22, 2008
In vitro sonodynamic cytotoxicity in regulated cavitation conditionsJhony El Maalouf, Jean-Christophe Béra, Laurent Alberti, et al.
The Oncologist|November 30, 2005
ET-743: a novel agent with activity in soft tissue sarcomasJérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.
BMC Cancer|September 2, 2014
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technologyArmelle Dufresne, Laurent Alberti, Mehdi Brahmi, et al.
International Journal of Cancer|July 15, 2004
IL-6 as an intracrine growth factor for renal carcinoma cell linesLaurent Alberti, Marie Cécile Thomachot, Thomas Bachelot, et al.
The American Journal of Surgical Pathology|November 6, 2019
Compound Clear Cell Sarcoma of the Skin-A Potential Diagnostic Pitfall: Report of a Series of 4 New Cases and a Review of the LiteratureBoštjan Luzar, Steven D Billings, Arnaud de la Fouchardiere, et al.
The American Journal of Surgical Pathology|December 15, 2017
Cutaneous Melanocytoma With CRTC1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell SarcomaLucie Cellier, Emilie Perron, Daniel Pissaloux, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
BMC Cancer|March 21, 2006
CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathwaysNathalie Voorzanger-Rousselot, Laurent Alberti, Jean-Yves Blay
Bulletin Du Cancer|March 8, 2005
Targeted cancer therapiesJean-Yves Blay, Axel Le Cesne, Laurent Alberti, et al.
Cancer Research|January 25, 2005
A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitorLaurent Alberti, Thoma Bachelot, Adeline Duc, et al.
Plos One|December 4, 2009
Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibodyAngélique Gougelet, Adeline Mansuy, Jean-Yves Blay, et al.
Ultrasonics|October 22, 2008
In vitro sonodynamic cytotoxicity in regulated cavitation conditionsJhony El Maalouf, Jean-Christophe Béra, Laurent Alberti, et al.
The Oncologist|November 30, 2005
ET-743: a novel agent with activity in soft tissue sarcomasJérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.
BMC Cancer|September 2, 2014
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technologyArmelle Dufresne, Laurent Alberti, Mehdi Brahmi, et al.
International Journal of Cancer|July 15, 2004
IL-6 as an intracrine growth factor for renal carcinoma cell linesLaurent Alberti, Marie Cécile Thomachot, Thomas Bachelot, et al.
The American Journal of Surgical Pathology|November 6, 2019
Compound Clear Cell Sarcoma of the Skin-A Potential Diagnostic Pitfall: Report of a Series of 4 New Cases and a Review of the LiteratureBoštjan Luzar, Steven D Billings, Arnaud de la Fouchardiere, et al.
The American Journal of Surgical Pathology|December 15, 2017
Cutaneous Melanocytoma With CRTC1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell SarcomaLucie Cellier, Emilie Perron, Daniel Pissaloux, et al.
Pageof 5